KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 128 filers reported holding KURA ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,871,517 | -13.8% | 1,849,947 | 0.0% | 9.37% | -2.6% |
| Q2 2023 | $19,572,439 | -13.5% | 1,849,947 | 0.0% | 9.62% | -18.0% |
| Q1 2023 | $22,624,852 | -1.5% | 1,849,947 | 0.0% | 11.74% | +19.7% |
| Q4 2022 | $22,957,842 | -9.1% | 1,849,947 | 0.0% | 9.81% | +20.7% |
| Q3 2022 | $25,270,000 | -25.5% | 1,849,947 | 0.0% | 8.13% | -11.0% |
| Q2 2022 | $33,910,000 | +14.0% | 1,849,947 | 0.0% | 9.13% | +9.7% |
| Q1 2022 | $29,747,000 | +14.9% | 1,849,947 | 0.0% | 8.32% | +56.2% |
| Q4 2021 | $25,899,000 | -25.3% | 1,849,947 | 0.0% | 5.33% | +4.4% |
| Q3 2021 | $34,650,000 | -10.2% | 1,849,947 | 0.0% | 5.10% | -2.1% |
| Q2 2021 | $38,571,000 | -26.2% | 1,849,947 | 0.0% | 5.21% | -16.8% |
| Q1 2021 | $52,298,000 | -11.4% | 1,849,947 | +2.3% | 6.26% | -2.3% |
| Q4 2020 | $59,049,000 | +47.3% | 1,807,982 | +38.2% | 6.41% | -29.0% |
| Q3 2020 | $40,077,000 | +88.0% | 1,307,982 | 0.0% | 9.04% | -13.0% |
| Q2 2020 | $21,320,000 | +2204.9% | 1,307,982 | +1306.4% | 10.39% | +811.1% |
| Q1 2020 | $925,000 | -1.1% | 93,000 | +36.8% | 1.14% | +182.9% |
| Q4 2019 | $935,000 | – | 68,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |